These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8971375)

  • 1. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
    Körbling M; Chan KW; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
    Bone Marrow Transplant; 1996 Nov; 18(5):885-90. PubMed ID: 8932841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
    Han XH; Shi YK; He XH; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
    Arseniev L; Tischler HJ; Battmer K; Südmeier I; Casper J; Link H
    Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of normal donors with rhG-CSF 16 micrograms/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation.
    Majolino I; Buscemi F; Scimé R; Indovina A; Santoro A; Vasta S; Pampinella M; Catania P; Fiandaca T; Caronia F
    Haematologica; 1995; 80(3):219-26. PubMed ID: 7545635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
    Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
    Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
    Majolino I; Cavallaro AM; Bacigalupo A; Rambaldi A; Falda M; Locatelli F; Raimondi R; Pucci G; Mordini N; Barbui T; Locatelli F; Rodeghiero F; Irrera G; Indovina A; Valbonesi M; Bellavita P; Tassi V; Perotti C; Soli M; Bresolin G
    Haematologica; 1997; 82(1):47-52. PubMed ID: 9107082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.